Skip to main content

Most Popular Robinhood Stocks: $IVR $JBLU $JNJ

The Market Signal was created as a platform to help investors, if you own (NYSE:IVR), (NASDAQ:JBLU) or (NYSE:JNJ) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

https://themarketsignal.com/Free-Report/NOW
(Click link above or copy, paste and hit enter in your browser for your report)

Invesco Mortgage Capital releases its Q2 2020 financial report

https://themarketsignal.com/Free-Report/IVR

(Click link above or copy, paste and hit enter in your browser for your report)
Invesco Mortgage Capital Inc. (NYSE:IVR) ended the latest trading session on Friday with a market capitalization of $554.86 Million and it is currently one of Robinhood's most popular stocks.

Invesco recently released its Q2 2020 financials earlier in August, revealing that it had a net loss of $299.9 million during the quarter which was equivalent to a $1.80 per share net loss. In comparison, the company reported a huge net loss of $1.627 billion in Q1 2020, which means that there was a slight improvement during the latest quarter.

Invesco's CEO John Anzalone state that the company's performance in Q2 2020 reflects the market disruption caused by the coronavirus pandemic. However, he expressed optimism in the fact that the company managed to boost liquidity and lower its leverage, thus improving its position to achieve better performance in the future.

JetBlue Airways increases flights plying the Steamboard-NYC route

https://themarketsignal.com/Free-Report/JBLU

(Click link above or copy, paste and hit enter in your browser for your report)

JetBlue Airways Corporation (NASDAQ:JBLU) closed Friday's trading session with a market capitalization of $3.26 billion and is one of the Robinhood stocks currently popular among traders.

JetBlue Airways recently announced that it will increase the number of flights on the Steamboat- New York route. The carrier revealed plans to ply that route twice per week despite the fact that there has been an increase in the coronavirus infection rate in Colorado.

The airline plans to implement the announced change on December 19 just in time to service more customers traveling to spend time with their families during the holidays. A one-way ticket from New York to Steamboat will cost as low as $407 in December. JetBlue will still implement the necessary safety measures to prevent the spread of COVID19 even as it increase the number of flights.

Johnson & Johnson to launch phase 3 trial of its coronavirus vaccine in September

https://themarketsignal.com/Free-Report/JNJ

(Click link above or copy, paste and hit enter in your browser for your report)

Johnson & Johnson (NYSE:JNJ) ended Friday's trading session with a market capitalization of $402.83 Billion and it is one of the investor favorites on Robinhood.

The company announced a few days ago that it will commence a late-stage trial for its pipeline coronavirus vaccine in September. A J&J spokesperson revealed that they plan to enroll up to 60,000 healthy volunteers into the phase 3 trial. The volunteers will be over 18-year-old from more than 180 locations in the U.S and also in other countries.

J&J was also pleased to announce that a combination of its drug Darzalex, the steroid called dexamethasone, and Amgen's Kyprolis has received the FDA's approval as a treatment for multiple myeloma. The drug combo called DKd will be administered to patients that have previously been treated with one, two, or three other therapies without yielding favorable results.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market, and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

comtex tracking

COMTEX_370468207/2700/2020-09-01T06:58:51

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.